Paul Rennie BSc, MBM, Grad Dip Commercial Law, MSTC, has sales, marketing, business development,operational and IP commercialisation experience in the biopharmaceutical sector.
Paul’s experience includes working for Boehringer Mannheim (now Roche Diagnostics), Merck KGGA as nationalsales and marketing manager and Soltec (FH Faulding Ltd) as their Director of business development. Paul alsoled the commercialisation of Recaldent® a novel biopharmaceutical arising from research at the dental school,University of Melbourne. Paul took an R&D project from the laboratory bench to a commercial product nowmarketed globally as an additive to oral care products. More recently Paul worked in a number of positions withMesoblast Ltd. Paul was the inaugural COO and moved into Executive Vice President New Product Developmentfor the adult stem cell company.
Paul’s experience includes working for Boehringer Mannheim (now Roche Diagnostics), Merck KGGA as nationalsales and marketing manager and Soltec (FH Faulding Ltd) as their Director of business development. Paul alsoled the commercialisation of Recaldent® a novel biopharmaceutical arising from research at the dental school,University of Melbourne. Paul took an R&D project from the laboratory bench to a commercial product nowmarketed globally as an additive to oral care products. More recently Paul worked in a number of positions withMesoblast Ltd. Paul was the inaugural COO and moved into Executive Vice President New Product Developmentfor the adult stem cell company.
Speaking In
11:45 AM - 12:00 PM
Tuesday, June 6
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
